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TO THE EDITOR
Early onset of psoriasis makes the under-
standing of pregnancy outcomes in
patients with psoriasis important. Studies
have shown that psoriasis is a risk factor
for adverse pregnancy outcomes (Cohen-
Barak et al., 2010; Yang et al., 2010) and
that pregnant women with psoriasis
are more likely to be depressed, obese,
and to smoke compared with women
without psoriasis (Bandoli et al., 2010).
Psoriasis shares pathological mecha-
nisms with other chronic inflammatory
diseases. Studies have demonstrated that
women with Crohn’s disease have an
increased risk of spontaneous abor-
tion (Malgarinos et al., 2007) and that
women with rheumatoid arthritis have
prolonged time to pregnancy (TTP)
(Jawaheer et al., 2011), and therefore
we wanted to determine whether
women with psoriasis are at increased
risk of fetal death and prolonged TTP.
We used data from the Danish
National Birth Cohort (DNBC),
containing information on 100,418
pregnancies enrolled from 1996–2003.
Information regarding reproductive his-
tory, lifestyle during pregnancy and
demographic characteristics was
obtained from telephone interviews.
Information regarding psoriasis was
self-reported. Data on pregnancy out-
comes were obtained from linkage with
the Danish National Patient Registry
(Lynge et al., 2011) and from the Civil
Registration System (Pedersen, 2011).
Details of the cohort and its structure
are given elsewhere (Olsen et al., 2001).
In all, 87,692 pregnancies were
eligible for the analysis of fetal death
(Supplementary Figure S1 online). Preg-
nancies eligible for analysis of TTP were
restricted to first-time pregnancies, to
avoid dependency between observa-
tions, resulting in 81,627 pregnancies.
Of the 87,692 pregnancies included
2,553 (3%) were of women with
psoriasis. Characteristics of the study
population are presented in Table 1
and Supplementary Table S1 online.
Compared to women without psoriasis,
women with psoriasis more often
smoked during pregnancy. Women with
psoriasis were older, and were more
often overweight with a body mass
index (BMI) of X25 (WHO, 2013).
Fetal death included spontaneous
abortions, stillbirths and twin births
in which one or both babies had died.
We analyzed the association between
psoriasis and fetal death using Cox
proportional hazards regression models,
giving hazard ratios (HRs) with 95%
confidence intervals (CIs). Analyses
were run with delayed entry and gesta-
tional age as the underlying time scale.
We took into account that some
women contributed with more than
one pregnancy, by including a robust
sandwich variance estimator handling
the within-person correlation between
pregnancies. Of the 2,553 pregnancies
in women with psoriasis, 36 (1.4%)
ended in fetal death compared with
1,119 (1.3%) fetal deaths in women
without psoriasis. This translated to a
HR of 1.05 (95% CI 0.75–1.46) after
adjustment (Table 2).Accepted article preview online 24 January 2014; published online 20 February 2014
Abbreviations: BMI, body mass index; DNCB, the Danish National Birth Cohort; TTP, time to pregnancy
E Harder et al.
Pregnancy and Psoriasis
www.jidonline.org 1747
The association between psoriasis and
TTP was investigated using a cross-sec-
tional design. TTP was coded in groups
of p5 months and 45 months. We
applied a logistic regression model to
the data, thus expressing the association
in terms of odds ratios (ORs) with 95%
CI. There was no statistically significant
increased risk of TTP 45 months in
women with psoriasis after adjustment
(OR¼ 1.05, 95% CI 0.96–1.15; Table 2).
Both models were adjusted for the
following confounders: Maternal pre-
pregnancy BMI (BMIo18.5, BMI 18.5–
24.9, BMI 25–29.9, and BMIX30), pre-
pregnancy alcohol consumption mea-
sured by units per week (0, ½–1½,
2–3½, 4–7, 7–14, 414), alcohol con-
sumption during pregnancy measured
by units per week (0, ½–1½, 2–3½,
44), smoking (yes/no), and maternal
age at conception (o20, 20–24, 25–29,
30–34, X35). All covariates were
chosen a priori.
The results from this study do not
support the hypothesis that psoriasis is
a risk factor for fetal death or that
psoriasis is a risk factor for prolonged
TTP. Our findings correspond with
the findings by Lima et al. (2012). The
authors did not find an increased risk of
spontaneous abortion associated with
psoriasis, but the number of outcomes
was limited and statistical power was
therefore low. Our findings conflict
with those of other former studies,
for example Ben-David et al., 2008,
who found an increased risk of recur-
rent spontaneous abortion in women
with psoriasis. The study included 145
pregnancies in 84 women with psoriasis
and 870 pregnancies in 860 women
without psoriasis, but had only 10
cases of recurrent spontaneous abor-
tion. The limited number of abortions
indicated underreporting (Ben-David
et al., 2008). Cohen-Barak et al. (2010)
found a 5.6 times increased risk of
spontaneous abortion in women with
psoriasis compared with women with-
out. However, this study was based on
only 35 women with moderate to
severe psoriasis, which contrasts with
our study in which the psoriasis
group, most likely, consisted of mainly
mild psoriasis cases. To the best of
our knowledge, information regarding
the association between psoriasis and
TTP has not been published before.
The prevalence of psoriasis was 3%,
which was similar to the general popula-
tion (Christophers, 2001; Nestle et al.,
2009). Women with psoriasis in DNBC
did not suffer from diabetes or hyperten-
sion more frequently when compared
with women without psoriasis. However,
we found that the women with psoriasis
were more likely to be obese before preg-
nancy and to smoke before and during
pregnancy compared with women with-
out psoriasis. These findings correspond
to earlier studies (Bandoli et al., 2010).
Together with the prospective study
design, our study population, including
large groups of exposed as well as
unexposed women, was of considerable
Table 1. Characteristics of women with and without psoriasis
þPsoriasis, n¼2,553 (3.0%)  Psoriasis, n¼85,139
Characteristics N Col % N Col %
Smoking
Yes 929 36.4 21,710 25.5
No 1,624 63.6 63,429 74.5
Maternal age
o20 years 23 1.0 839 1.0
20–24 years 274 10.7 9,923 11.6
25–29 years 951 37.3 35,350 41.5
30–34 years 939 36.8 29,156 34.2
X35 years 366 14.3 9,871 11.6
Maternal pre-pregnancy BMI
Underweight (BMI o18.5) 99 3.9 3,848 4.5
Normal weight (BMI X18.5 to 24.9) 1,637 64.1 57,823 67.9
Overweight (BMI 25–29.9) 554 21.7 16,437 19.3
Severe overweight (BMI X30) 263 10.3 7,031 8.3
Hypertension
Yes 250 9.8 7,690 9.0
No 2,303 90.2 77,449 91.0
Diabetes
Yes 8 0.3 263 0.3
No 2,545 99.7 84,876 99.7
Abbreviation: BMI, body mass index.
Table 2. Crude and adjusted risk estimates for fetal death and prolonged
TTP in women with and without psoriasis
Psoriasis
Fetal death
(n¼1,155) Crude HR 95% CI Adj. HR1 95% CI
Yes 36 1.10 0.79–1.54 1.05 0.75–1.46
No 1,119 1 — 1 —
Psoriasis
TTP 45 months
(n¼22,869) Crude OR 95% CI Adj. OR1 95% CI
Yes 713 1.11 1.01–1.21 1.05 0.96–1.15
No 22,156 1 — 1 —
Abbreviations: CI, confidence interval; HR, hazard ratio; OR, odds ratios; TTP, time to pregnancy.
1Adjusted for maternal pre-pregnancy body mass index, smoking, weekly alcohol consumption before
pregnancy, and maternal age.
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advantage. Also, it was an advantage
that we were able to take within-person
correlation into account to avoid artifi-
cial estimates. This study also had some
limitations. The study population were
women who had participated in the first
pregnancy interview, which took place
early in the second trimester, and the
risk of fetal deaths in the first trimester—
which constitute the largest proportion
of fetal deaths—could therefore not be
estimated. In this study, information on
psoriasis was self-reported. This could
have introduced misclassification of
mothers with psoriasis, but it was prob-
ably confined to women who had mild
psoriasis and were misclassified as
unexposed. This might have driven the
association toward displaying no differ-
ence between women with and without
psoriasis. In the DNBC, there was no
information on the severity of psoriasis.
We had no access to information
regarding psoriasis treatment before or
during pregnancy. However, most likely
only a few women—if any—were given
systemic treatments as these treatments
are normally avoided for women of
childbearing age. An issue when study-
ing TTP, is the fact that only women
who achieve pregnancy are included.
This excludes a whole group of women
who never become pregnant.
In conclusion, in this large prospec-
tive cohort study we found that psoriasis
was not a risk factor for fetal death after
the first trimester or for prolonged TTP in
patients with mainly mild to moderate
psoriasis.
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TO THE EDITOR
Our understanding of skin biology has
been greatly enhanced by studying gen-
odermatoses, as this has guided the
discovery of key genes responsible for
skin function (Chamcheu et al., 2011).
Palmoplantar keratodermas (PPKs) are a
group of rare, heterogeneous hereditary
diseases characterized by epidermal
hyperkeratosis of palmoplantar skin.
They are typically classified according
to their mode of inheritance or morpho-
logic features of the disease. However,
the clinical picture is often complicated
by significant interfamilial and intrafa-
milial variation in lesional appearance
(Kelsell and Stevens, 1999).
In this study, we focused on punctate
palmoplantar keratoderma type 1
(PPKP1), also known as punctate PPK,
or Buschke–Fischer–Brauer (OMIM
148600). The inheritance of punctate
PPK is commonly autosomal dominant;
however, it sometimes presents as an
acquired disease (Emmert et al., 2003).Accepted article preview online 3 January 2014; published online 30 January 2014
Abbreviation: PPK/PPKP1, palmoplantar keratoderma/palmoplantar keratoderma, punctate, type 1
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